Country: নেদারল্যান্ডস
ভাষা: ইংরেজি
সূত্র: HMA (Heads of Medicines Agencies)
benazepril hydrochloride 5 mg
Animalcare Limited
QC09AA07
Film coated tablet
benazepril
Dogs
2011-10-28
Revised: May 2012 AN: 00040/2012 Page 1 of 7 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Benazecare Flavour 5 mg Tablets for Dogs and Cats. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION ACTIVE SUBSTANCE: Benazepril hydrochloride 5mg For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Tablet Beige oblong tablet with breakline on both sides. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs and cats. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Dogs Treatment of congestive heart failure in dogs. Cats Reduction of proteinuria associated with chronic kidney disease. 4.3 CONTRAINDICATIONS Do not use in case of hypersensitivity to the active substance or to any of the excipients. Do not use in cases of hypotension, hypovolaemia, hyponatraemia or acute renal failure. Do not use in cases of cardiac output failure due to aortic or pulmonary stenosis. Do not use during pregnancy or lactation (section 4.7). 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None. Revised: May 2012 AN: 00040/2012 Page 2 of 7 4.5 SPECIAL PRECAUTIONS FOR USE i. Special precautions for use in animals No evidence of renal toxicity of the veterinary medicinal product has been observed (in dogs or cats) during clinical trials, however, as is routine in cases of chronic kidney disease, it is recommended to monitor plasma creatinine, urea and erythrocyte counts during therapy. The efficacy and safety of benazepril hydrochloride_ _has not been established সম্পূর্ণ নথি পড়ুন